Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Beyer (Innsbruck, Austria), A. Pizzini (Innsbruck, Austria), A. Boehm (Innsbruck, Austria), J. Loeffler-Ragg (Innsbruck, Austria), G. Weiss (Innsbruck, Austria), G. Feuchtner (Innsbruck, Austria), A. Bauer (Innsbruck, Austria), G. Friedrich (Innsbruck, Austria), F. Plank (Innsbruck, Austria). Underappreciation of coronary artery disease in patients with COPD. 5116

Member's Comments

No comment yet.

Related content which might interest you: OSA and coronary artery disease Source: Sleep and Breathing Conference 2021 Year: 2021 The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Heart failure and coronary artery disease in lung disease Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018 Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006 Lipid profile in COPD patients with coronary artery disease comorbidity Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 COPD as a risk factor for carotid artery disease (CAD) and low-extremity artery disease (LEAD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Lower extremity and carotid artery disease in COPD Source: ERJ Open Res, 2 (4) 00037-2016; 10.1183/23120541.00037-2016 Year: 2016 Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Carotid atherosclerosis in COPD patients Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013 The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease Source: Eur Respir J, 52 (3) 1800458; 10.1183/13993003.00458-2018 Year: 2018 Analysis of atherosclerosis in patients with chronic obstructive pulmonary disease by carotid ultrasonography Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Prognostic significance of obstruction severity in COPD patients admitted to coronary artery bypass grafting. Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Dyspnea in patients with coronary artery disease: is it related with physiologic measurements? Source: Eur Respir J 2001; 18: Suppl. 33, 300s Year: 2001